Paul Sekhri, new CEO of vTv Therapeutics, touts potential for diabetes drug as he looks to turn biotech around
"My focus is to turn the company around and get it back on track," said Paul Sekhri, the new CEO of vTv Therapeutics.
"My focus is to turn the company around and get it back on track," said Paul Sekhri, the new CEO of vTv Therapeutics.